Diffusion MRI is an early biomarker of overall survival benefit in IDH wild-type recurrent glioblastoma treated with immune checkpoint inhibitors is a research paper published in Neuro-Oncology (2021). On theSindex it has a DataRank of 0. It has been cited 26 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
American Cancer Society
Grant: RSG-15-003-01-CCE
UCLA SPORE in Brain Cancer
Grant: 1P50CA211015-01A1
UCLA SPORE in Brain Cancer
UCLA SPORE in Brain Cancer
Grant: 1R21CA223757-01
Metabolic MRI for quantifying aerobic glycolysis and immune function in gliomas
NIGMS
Grant: GM008042
NCI NIH HHS
Grant: P50 CA211015
NCI NIH HHS
Grant: R21 CA223757
EPA
Grant: EP-C-15-003
NIGMS NIH HHS
Grant: T32 GM008042
National Institutes of Health
Grant: 5T32GM008042-27
Medical Scientist Training Program
NIH
UCLA Jonsson Comprehensive Cancer Center Seed Grant
FWCI
1.63
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals